TY - JOUR
T1 - Degradation of p27Kip1 at the G0-G1 Transition Mediated by a Skp2-independent Ubiquitination Pathway
AU - Hara, Taichi
AU - Kamura, Takumi
AU - Nakayama, Keiko
AU - Oshikawa, Kiyotaka
AU - Hatakeyama, Shigetsugu
AU - Nakayama, Kei Ichi
PY - 2001/12/28
Y1 - 2001/12/28
N2 - Targeting of the cyclin-dependent kinase inhibitor p27Kip1 for proteolysis has been thought to be mediated by Skp2, the F-box protein component of an SCF ubiquitin ligase complex. Degradation of p27Kip1 at the G0-G1 transition of the cell cycle has now been shown to proceed normally in Skp2-/- lymphocytes, whereas p27 Kip1 proteolysis during S-G2 phases is impaired in these Skp2-deficient cells. Degradation of p27Kip1 at the G 0-G1 transition was blocked by lactacystin, a specific proteasome inhibitor, suggesting that it is mediated by the ubiquitin-proteasome pathway. The first cell cycle of stimulated Skp2 -/- lymphocytes appeared normal, but the second cycle was markedly inhibited, presumably as a result of p27Kip1 accumulation during S-G2 phases of the first cell cycle. Polyubiquitination of p27 Kip1 in the nucleus is dependent on Skp2 and phosphorylation of p27Kip1 on threonine 187. However, polyubiquitination activity was also detected in the cytoplasm of Skp2-/- cells, even with a threonine 187 → alanine mutant of p27Kip1 as substrate. These results suggest that a polyubiquitination activity in the cytoplasm contributes to the early phase of p27Kip1 degradation in a Skp2-independent manner, thereby promoting cell cycle progression from G0 to G 1.
AB - Targeting of the cyclin-dependent kinase inhibitor p27Kip1 for proteolysis has been thought to be mediated by Skp2, the F-box protein component of an SCF ubiquitin ligase complex. Degradation of p27Kip1 at the G0-G1 transition of the cell cycle has now been shown to proceed normally in Skp2-/- lymphocytes, whereas p27 Kip1 proteolysis during S-G2 phases is impaired in these Skp2-deficient cells. Degradation of p27Kip1 at the G 0-G1 transition was blocked by lactacystin, a specific proteasome inhibitor, suggesting that it is mediated by the ubiquitin-proteasome pathway. The first cell cycle of stimulated Skp2 -/- lymphocytes appeared normal, but the second cycle was markedly inhibited, presumably as a result of p27Kip1 accumulation during S-G2 phases of the first cell cycle. Polyubiquitination of p27 Kip1 in the nucleus is dependent on Skp2 and phosphorylation of p27Kip1 on threonine 187. However, polyubiquitination activity was also detected in the cytoplasm of Skp2-/- cells, even with a threonine 187 → alanine mutant of p27Kip1 as substrate. These results suggest that a polyubiquitination activity in the cytoplasm contributes to the early phase of p27Kip1 degradation in a Skp2-independent manner, thereby promoting cell cycle progression from G0 to G 1.
UR - http://www.scopus.com/inward/record.url?scp=0035966104&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035966104&partnerID=8YFLogxK
U2 - 10.1074/jbc.M107274200
DO - 10.1074/jbc.M107274200
M3 - Article
C2 - 11682478
AN - SCOPUS:0035966104
SN - 0021-9258
VL - 276
SP - 48937
EP - 48943
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 52
ER -